FUNDING & OPPORTUNITIES 

The Milner Therapeutics Institute is part of the School of Biological Sciences and the School of Clinical Medicine at the University of Cambridge, and is dedicated to the conversion of ground breaking science into therapies. Based on the Cambridge Biomedical Campus, the institute is surrounded by a global therapeutic alliance of SMEs, pharma companies, academic institutions and venture capital firms.

We periodically run calls that offer physical space for startup companies, as well as opportunities for funding and collaboration. Please see below for a list of our current opportunities.

Bio-Incubator Space

Are you a start-up interested in bio-incubator space?

We currently have a unique opportunity for you to be part of a vibrant Institute in a much sought after location on Cambridge Biomedical Campus. The Milner Therapeutics Institute has limited space for research intensive, R&D companies, working in an areas related to the Institute’s expertise (e.g. functional genomics, early target discovery, therapeutics). You will be working side by side with academics, entrepreneurs and industry scientists.

To discuss, please contact contact@milner.cam.ac.uk

 

Bio-spark Entrepreneurial Programme

 

Applications are now open for the Bio-spark Entrepreneurial Programme (2023/2024)

Bio-spark is an entrepreneurial programme and support system for early-career academics considering a career in business and enterprise. It is a fellowship programme that provides internships at Pharma, Biotech or Venture partners, mentorship for those with ideas for setting up companies, and networking opportunities for all Bio-spark fellows. It is a “learn by experience” programme that runs outside of PhD and Postdoc responsibilities.

The closing date for Challenge-solving and Exploring Fellowships is 28th April 2023.
The closing date for Company-seeding Fellowships is 1st September 2023.

To find out more about the Bio-spark entrepreneurial programme, visit their webpage.

Alexander Crummell MPhil and PhD Scholarships

Closing date for PhD students applying to Cambridge Biosciences DTP 4-year PhD programme: 5th December, 2023
Closing date for all other MPhil scholarship and for PhD scholarships: 4th January, 2024

In collaboration with Queens’ College, Cambridge, the School of Biological Sciences, University of Cambridge is inviting applications for the Alexander Crummell MPhil and PhD Scholarships.
These scholarships are for Home (UK fee rate) students with Black or Black-Mixed ethnicity applying for a degree in a science-based subject at the University of Cambridge.

Eligible MPhil courses:

  • MPhil in Basic and Translational Neuroscience
  • MPhil in Biological Sciences by Advanced Study (multiple pathways)
  • MPhil in Biological Sciences by Thesis (multiple departments)

The MPhil Scholarship includes:

  • Maintenance at £18,625 pa pro-rata
  • University fees at the home rate

The PhD Scholarship includes:

  • Maintenance for 4 years at the UKRI level (£18,622 in 2023)
  • University fees at the home rate
  • Research consumables for 4 years (£18,000 in total)

PhD students also undertake a 3-month Professional Internship for PhD students (PIPS) during their study, and will participate in training and cohort-building events alongside other funded students.

For more information and to apply, follow the links below.
MPhil Scholarship: postgradschl.lifesci.cam.ac.uk/funding/alexander-crummell-mphil-scholarships
Phd Scholarship: postgradschl.lifesci.cam.ac.uk/funding/alexander-crummell-phd-scholarships

Consortium Call

Our pharma partners in the Milner Therapeutics Consortium are working together with academics at the University, Babraham and Wellcome Sanger Institutes to better understand disease mechanisms and to discover and validate new therapeutic targets. These pre-clinical projects range from reagent sharing and 6-month pilots to 2-year postdoctoral funded collaborations and are expected to lead to joint publications with the company partners.

Visit the Consortium Call page for more information.

MILNER THERAPEUTICS SYMPOSIUM

X